COLUMN: Action on 340B Contract Pharmacies Turns to the States

Ted Slafsky, publisher and CEO of 340B Report, writes the second part of his two-part column on the Senate "group of six" 340B discussion draft.
As we approach the 16-month mark since we had pivotal arguments over the 340B contract pharmacy program in two federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Genesis CEO Praises Court Decision, Blasts HRSA, NACHC, State Primary Care Association

Tony Megna, CEO and general counsel of Genesis Healthcare, shared his first public comments with 340B Report on a key 340B court decision.
In his first public comments since a key federal court decision on the 340B patient definition, the leader of a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amid Possible Coming Enforcement, PhRMA Again Asks Court to Block Louisiana’s 340B Contract Pharmacy Law

In a recent federal court filing, Louisiana Attorney General Liz Murrill's office said it had not moved to enforce a state 340B contract pharmacy law.
After Louisiana signaled plans to possibly enforce its state 340B contract pharmacy law, a powerful drug industry trade group has [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Arkansas Looks to Amend Temporary Contract Pharmacy Agreement with Novo Nordisk

Arkansas Insurance Department office sign
The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.
After hospitals in Arkansas raised concerns over details of an agreement by Novo Nordisk to temporarily loosen contract pharmacy restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Arizona State Senators Introduce Latest 340B Contract Pharmacy Bill

Two influential Arizona state senators recently introduced a bill that would prohibit drugmaker restrictions on 340B contract pharmacy use.
Two high-ranking Republican Arizona state senators have introduced a bill that would bar drug manufacturer restrictions on 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HIV/AIDS Group Continues Legal Fight with Apexus Over 340B Prime Vendor Contract

AHF has asked a federal appeals court to reverse an earlier court's decision to dismiss a case against Apexus over its provision of 340B sub-ceiling price discounts on drugs.
The AIDS Healthcare Foundation (AHF) recently urged a federal appeals court to reverse a lower court’s decision to dismiss its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Provider-Drugmaker Lobbying Group Adds Two More Manufacturers

Two additional drugmakers have joined 340B Working Table, the joint lobbying 340B group that was founded by an influential health system, health center, and pharmaceutical manufacturer.
A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added two more [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

High-Ranking GOP Lawmakers Introduce Bills to Quantify 340B Use Among ‘Noncitizens’

Sen. Bill Cassidy (R-La.) and other influential Republican lawmakers introduced companion bills calling for a government report on 340B use among people living in the country without legal permission.
Influential Republican lawmakers have introduced companion bills in the U.S. House and Senate that call for a government report on [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Health System’s Suit Against Drugmakers Seeks to Recover ‘Hundreds of Millions in Overpayments’

Calif-based Adventist Health System/West and four drugmakers are clashing in federal district court over allegations of 340B overcharges.
A California health system is continuing a previously sealed whistleblower case it first filed in 2021 against several pharmaceutical companies. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders

A Medicaid drug rebate policy change that recently took effect could lead to reduced 340B savings and drug discontinuations.
A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live